Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

12.5%

2 terminated/withdrawn out of 16 trials

Success Rate

86.7%

+0.2% vs industry average

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT00578240Active Not Recruiting

Molecular Studies and Clinical Correlations in Human Prostatic Disease

Role: collaborator

NCT00877682Not ApplicableCompleted

Prostate Conformal Cryotherapy

Role: collaborator

NCT01728103Terminated

Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays

Role: lead

NCT02026752Completed

Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay

Role: lead

NCT00973362Phase 3Completed

Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System

Role: lead

NCT00978848Completed

Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing

Role: collaborator

NCT01656174Completed

Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross

Role: lead

NCT01702272Completed

Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS

Role: lead

NCT01427023Completed

Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing

Role: lead

NCT01733069Completed

Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System

Role: lead

NCT01638637Completed

Prospective Collection of Female and Male Specimens for PANTHER® System Testing

Role: lead

NCT01358799Withdrawn

Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System

Role: lead

NCT01694875Completed

Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System

Role: lead

NCT01024959Not ApplicableCompleted

Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result

Role: lead

NCT01446198Completed

Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System

Role: lead

NCT01384370Completed

APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results

Role: lead

All 16 trials loaded